Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SH) has received the registration certificate for the drug acetaminophen tablets.

Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SH) announced that recently, the company has received the "Drug Registration Certificate" for the acetaminophen tablets issued by the National Medical Products Administration. The indications for this drug include the treatment of pain and inflammation symptoms caused by osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Acetaminophen is a non-steroidal anti-inflammatory drug with a wide range of clinical applications in the treatment and relief of pain, showing significant anti-inflammatory, analgesic, and antipyretic effects. The formulation previously marketed by the company was enteric-coated tablets, and the newly approved formulation is tablets.